AKESOgen Competitors and Similar CompaniesClear all
Aceragen's competitors and similar companies include F-star Biotechnology.
 Aceragen Aceragen (formerly known as Idera Pharmaceuticals) is engaged in the discovery and development of novel synthetic DNA and RNA-based drug candidates. |  F-star Biotechnology F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology. | |
Founding Date | Founding Date 1989 | Founding Date 2006 |
Type | Type Public | Type Private |
Tags | ||
Locations | Locations Durham, US HQ | Locations Cambridge, GB HQ Wien, AT Cambridge, US |
Employees | Employees 3642% decrease | Employees 39 |
Financial | ||
Revenue (est.) | Revenue (est.) $4.9m (FY, 2022) | Revenue (est.) £18.7m (FY, 2018) |
Net income | Net income ($23.4m) (FY, 2022) | Net income (£2.6m) (FY, 2018) |
Funding | ||
Total funding raised | Total funding raised $ 13.8m | Total funding raised $ 57.3m |
For sources of this data, please see the company profile
View Company Profiles
F-star Biotechnology
HQ
Cambridge, GB
Employees
39
F-star is developing a pipeline of novel bispecific antibodies with a therapeutic focus in immuno-oncology and oncology.
View company